SCHEMBL24450953

SCHEMBL24450953

COc1ncnc2c1ncn2[C@@H]1O[C@H](CN=[N+]=[N-])[C@H]2OC(C)(C)O[C@H]21

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 1/20 0.53
▸ PI4K2B Q8TCG2 1/20 0.53
▸ PI4K2A Q9BTU6 1/20 0.53
▸ PI4KB Q9UBF8 1/20 0.53
▸ AHCY P23526 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.49
▸ P2RX3 P56373 3/20 0.47
▸ P2RX1 P51575 2/20 0.47
▸ P2RX4 Q99571 2/20 0.47
▸ AMD1 P17707 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ HIF1A Q16665 1/20 0.38
▸ GAA P10253 1/20 0.36
▸ SLC29A1 Q99808 1/20 0.36
▸ ADK P55263 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953837 0.87 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBAHCY
SCHEMBL16141172 0.87 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBAHCY
SCHEMBL13610771 0.87 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBAHCY
SCHEMBL23120996 0.87 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBAHCY
SCHEMBL13435086 0.87 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBAHCY
SCHEMBL13623625 0.87 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBAHCY
SCHEMBL24450945 0.84 PI4KA (0.74) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL24450655 0.84 PI4KA (0.61) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL19443155 0.82 CCNB2 (0.47) PI4KAPI4K2BPI4K2API4KBTDP1
SCHEMBL13834839 0.82 CCNB2 (0.47) PI4KAPI4K2BPI4K2API4KBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220162209-A1 SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162209-A1 SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF ADSL, SLC35B2, ADORA1 PI4KA 4470/4885PI4K2B 4804/4885PI4K2A 4831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback